Authors: | Ramirez-Fort, M. K.; Mahase, S. S.; Osborne, J. R.; Lange, C. S. |
Article Title: | Theragnostic target, prostate-specific membrane antigen - Also specific for nonprostatic malignancies |
Keywords: | immunohistochemistry; osteosarcoma; cancer survival; protein expression; unclassified drug; overall survival; drug approval; disease free survival; cancer staging; glioma; endometrium carcinoma; diagnostic accuracy; sensitivity and specificity; melanoma; ovary cancer; protein targeting; tumor biopsy; in vitro study; enzyme activity; renal cell carcinoma; monoclonal antibody; gleason score; lung metastasis; capromab pendetide in 111; monoclonal antibody j591; prostate specific membrane antigen; dosimetry; breast carcinoma; brachytherapy; recurrent disease; merkel cell carcinoma; lung carcinoma; external beam radiotherapy; radioisotope; colon carcinoma; half life time; ex vivo study; glutamic acid; biochemical recurrence; bone marrow toxicity; glutamate carboxypeptidase ii; tumor microenvironment; clinical trial (topic); adverse event; phase 1 clinical trial (topic); mouth squamous cell carcinoma; scaffold protein; kidney cell; yttrium 90; actinium 225; n acetylaspartylglutamic acid; gamma glutamyl hydrolase; glutamic acid derivative; lutetium 177; cancer prognosis; tetraxetan; multiparametric magnetic resonance imaging; human; priority journal; article; endometrial disease; physiological process; positron emission tomography-computed tomography; solid malignant neoplasm; pteroptin; kidney tissue; n acetyl aspartylglutamate; liver tissue; spleen tissue |
Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
Volume: | 101 |
Issue: | 3 |
ISSN: | 0360-3016 |
Publisher: | Elsevier Inc. |
Date Published: | 2018-07-01 |
Start Page: | 646 |
End Page: | 649 |
Language: | English |
DOI: | 10.1016/j.ijrobp.2018.03.061 |
PROVIDER: | scopus |
PUBMED: | 29893276 |
DOI/URL: | |
Notes: | Article -- Export Date: 2 July 2018 -- Source: Scopus |